Mr. Koenraad Van Loo
CEO & Managing Director @ SFPI-FPIM
Antwerp, Belgium
Mr. Koenraad Van Loo is a seed investor at SFPI-FPIM in Antwerp focused on Health Care and Life Science. Koen Van Loo is the CEO and Managing Director of SFPI-FPIM.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Mr. Koenraad Van Loo invests in
Stages Mr. Koenraad Van Loo invests in
Countries Mr. Koenraad Van Loo invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 1 (50%)
- Life Science 1 (50%)
- Therapeutics 1 (50%)
- Biotechnology 1 (50%)
- Semiconductor 1 (50%)
Stage
- Seed 1 (50%)
- Series A 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
MICLEDI Microdisplays
|
MICLEDI Microdisplays is an experienced executive in the semiconductor industry, | $8.2M / Seed / Apr 03, 2021 | |
ExeVir Bio
|
ExeVir Bio is a Belgium-based company that develops single-domain antibody-based therapies that help patients ward off viral infections. The company is harnessing a llama-derived antibody technology platform to generate robust antiviral therapies providing broad protection against coronaviruses. They using a highly innovative and clinicallyvalidated VHH technology to develop treatments for viral infections that may pose a significant global threat. ExeVir Bio develops a rapid response platform for antivirals. This platform technology enables an agile response to new health threats thanks to its short throughput time to generate drug candidates. The resulting protein-based therapeutics are sufficiently stable and easy to produce at a reasonable cost to enable true global access.ExeVir Bio was founded in 2020 and is headquartered in Zwijnaarde, Belgium. | $49.2M / Series A / Jul 28, 2020 |
Co-Investors
About SFPI-FPIM
The Federal Holding and Investment Company (SFPI-FPIM) centrally manages the federal government’s shareholdings, cooperates with the government on specific projects and pursues its own investment policy in the interests of the Belgian economy.
SFPI-FPIM Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Mr. Johan de Ketelbutter
Adviser-General
|
|||
|
Mr. Koenraad Van Loo
CEO & Managing Director
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Mr. Koenraad Van Loo invest in?
Mr. Koenraad Van Loo invests primarily in Health Care, Life Science and Therapeutics startups, most often at Seed and Series A stage. Most of the 2 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Mr. Koenraad Van Loo?
Public channels for Mr. Koenraad Van Loo include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Mr. Koenraad Van Loo last invest?
The most recent investment recorded for Mr. Koenraad Van Loo closed in Apr 2021. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
